Advertisement
Screener

Concert Pharmaceuticals, Inc. Comprehensive Income

Concert Pharmaceuticals, Inc. Comprehensive Income

Concert Pharmaceuticals, Inc. reported Comprehensive Income of -$28.95 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-11-07

  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$28.95M.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$23.52M, a 533.62% decline year-over-year.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-03-31 was -$37.77M.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was -$36.13M.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$80.07M.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$74.79M.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$78.06M.
  • Concert Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$55.75M, a 158.54% decline from fiscal 2017.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2022-09-30-$28.95M
10-Q · filed 2022-11-07
-$52.47M
derived: sum of 2 quarters · filed 2022-11-07
-$90.24M
10-Q · filed 2022-11-07
-$126.37M
derived: sum of 4 quarters · filed 2022-11-07
2022-06-30-$23.52M
10-Q · filed 2022-08-04
-$61.28M
10-Q · filed 2022-08-04
-$97.41M
derived: sum of 3 quarters · filed 2022-08-04
-$124.09M
derived: sum of 4 quarters · filed 2022-11-07
2022-03-31-$37.77M
10-Q · filed 2022-05-05
-$73.90M
derived: sum of 2 quarters · filed 2022-05-05
-$100.58M
derived: sum of 3 quarters · filed 2022-11-07
-$95.15M
derived: sum of 4 quarters · filed 2022-11-07
2021-12-31-$36.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$62.81M
derived: sum of 2 quarters · filed 2022-11-07
-$57.38M
derived: sum of 3 quarters · filed 2022-11-07
-$80.07M
10-K · filed 2022-03-03
2021-09-30-$26.68M
10-Q · filed 2022-11-07
-$21.25M
derived: sum of 2 quarters · filed 2022-11-07
-$43.94M
10-Q · filed 2022-11-07
-$66.42M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$5.42M
10-Q · filed 2022-08-04
-$17.26M
10-Q · filed 2022-08-04
-$39.74M
derived: sum of 3 quarters · filed 2022-08-04
-$58.79M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$22.68M
10-Q · filed 2022-05-05
-$45.17M
derived: sum of 2 quarters · filed 2022-05-05
-$64.22M
derived: sum of 3 quarters · filed 2022-05-05
-$77.52M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$22.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$41.53M
derived: sum of 2 quarters · filed 2022-03-03
-$54.84M
derived: sum of 3 quarters · filed 2022-03-03
-$74.79M
10-K · filed 2022-03-03
2020-09-30-$19.05M
10-Q · filed 2021-11-09
-$32.36M
derived: sum of 2 quarters · filed 2021-11-09
-$52.31M
10-Q · filed 2021-11-09
-$72.79M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$13.31M
10-Q · filed 2021-08-05
-$33.26M
10-Q · filed 2021-08-05
-$53.74M
derived: sum of 3 quarters · filed 2021-08-05
-$70.97M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$19.95M
10-Q · filed 2021-05-04
-$40.44M
derived: sum of 2 quarters · filed 2021-05-04
-$57.66M
derived: sum of 3 quarters · filed 2021-05-04
-$76.28M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31-$20.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$37.71M
derived: sum of 2 quarters · filed 2021-02-25
-$56.33M
derived: sum of 3 quarters · filed 2021-02-25
-$78.06M
10-K · filed 2021-02-25
2019-09-30-$17.22M
10-Q · filed 2020-11-05
-$35.85M
derived: sum of 2 quarters · filed 2020-11-05
-$57.58M
10-Q · filed 2020-11-05
-$78.32M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$18.62M
10-Q · filed 2020-08-06
-$40.35M
10-Q · filed 2020-08-06
-$61.10M
derived: sum of 3 quarters · filed 2020-08-06
-$78.40M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$21.73M
10-Q · filed 2020-04-30
-$42.47M
derived: sum of 2 quarters · filed 2020-04-30
-$59.77M
derived: sum of 3 quarters · filed 2020-04-30
-$72.94M
derived: sum of 4 quarters · filed 2020-04-30
2018-12-31-$20.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$38.05M
derived: sum of 2 quarters · filed 2020-02-27
-$51.22M
derived: sum of 3 quarters · filed 2020-02-27
-$55.75M
10-K · filed 2020-02-27
2018-09-30-$17.30M
10-Q · filed 2019-11-07
-$30.47M
derived: sum of 2 quarters · filed 2019-11-07
-$35.01M
10-Q · filed 2019-11-07
-$41.41M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$13.17M
10-Q · filed 2019-08-01
-$17.71M
10-Q · filed 2019-08-01
-$24.11M
derived: sum of 3 quarters · filed 2019-08-01
$103.93M
derived: sum of 4 quarters · filed 2019-08-01
2018-03-31-$4.54M
10-Q · filed 2019-05-02
-$10.94M
derived: sum of 2 quarters · filed 2019-05-02
$117.10M
derived: sum of 3 quarters · filed 2019-05-02
$104.06M
derived: sum of 4 quarters · filed 2019-05-02
2017-12-31-$6.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$121.64M
derived: sum of 2 quarters · filed 2019-02-28
$108.60M
derived: sum of 3 quarters · filed 2019-02-28
$95.24M
10-K · filed 2019-02-28
2017-09-30$128.04M
10-Q · filed 2018-11-01
$115.00M
derived: sum of 2 quarters · filed 2018-11-01
$101.64M
10-Q · filed 2018-11-01
$89.56M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$13.04M
10-Q · filed 2018-08-02
-$26.40M
10-Q · filed 2018-08-02
-$38.48M
derived: sum of 3 quarters · filed 2019-02-28
-$49.85M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$13.36M
10-Q · filed 2018-05-03
-$25.44M
derived: sum of 2 quarters · filed 2019-02-28
-$36.81M
derived: sum of 3 quarters · filed 2019-02-28
-$50.24M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$12.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$23.45M
derived: sum of 2 quarters · filed 2019-02-28
-$36.88M
derived: sum of 3 quarters · filed 2019-02-28
-$50.71M
10-K · filed 2019-02-28
2016-09-30-$11.37M
10-Q · filed 2017-11-09
-$24.80M
derived: sum of 2 quarters · filed 2017-11-09
-$38.63M
10-Q · filed 2017-11-09
2016-06-30-$13.43M
10-Q · filed 2017-08-08
-$27.26M
10-Q · filed 2017-08-08
2016-03-31-$13.83M
10-Q · filed 2017-05-02
2015-09-30-$8.52M
10-Q · filed 2016-11-08
$32.51M
derived: sum of 2 quarters · filed 2016-11-08
$23.52M
10-Q · filed 2016-11-08
2015-06-30$41.03M
10-Q · filed 2016-08-09
$32.05M
10-Q · filed 2016-08-09
2015-03-31-$8.98M
10-Q · filed 2016-05-05
2014-09-30-$7.83M
10-Q · filed 2015-11-05
-$15.80M
derived: sum of 2 quarters · filed 2015-11-05
-$22.76M
10-Q · filed 2015-11-05
2014-06-30-$7.97M
10-Q · filed 2015-08-05
-$14.93M
10-Q · filed 2015-08-05
2014-03-31-$6.96M
10-Q · filed 2015-05-11